Keyphrases
Start of Treatment
100%
Botulinum Neurotoxin (BoNT)
100%
Oromandibular Dystonia
100%
Mental Distress
100%
Orofacial Dysfunction
100%
Visual Analog Scale
27%
Temporomandibular Disorders
18%
Patient Health Questionnaire
18%
Spearman Rank Correlation
9%
Oral Medication
9%
Disease Treatment
9%
Wilcoxon
9%
Dentists
9%
Non-parametric Analysis
9%
Tongue Movement
9%
Difficult-to-treat
9%
Course Effect
9%
Functional Limitations
9%
Muscle Involvement
9%
Overall Impact
9%
Botulinum Toxin Injection
9%
Jaw Movement
9%
Monotherapy
9%
Treatment Effect
9%
Disease Course
9%
Muscle Activity
9%
Neurologist
9%
Medicine and Dentistry
Clostridium Botulinum Type A
100%
Oromandibular Dystonia
100%
Jaw
36%
Visual Analog Scale
27%
Functional Limitation
27%
Jaw Disease
18%
Patient Health Questionnaire
18%
Monotherapy
9%
Treatment Effect
9%
Dentist
9%
Diagnostic Error
9%
Tongue
9%
Muscle Contraction
9%
Disease Course
9%
Combination Therapy
9%
Neuroscience
Dystonia
100%
Clostridium Botulinum Type A
100%
Jaw
36%
Biochemistry, Genetics and Molecular Biology
Clostridium Botulinum Type A
100%
Ordo
33%
Muscle Contraction
33%
Pharmacology, Toxicology and Pharmaceutical Science
Oromandibular Dystonia
100%